Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
§10(1) TO 10(3) shift due to altered BE results §10(1) TO 10(3) shift due to altered BE results §10(1) TO 10(3) shift due to altered BE results	Tina	2013-05-24 18:02	2	2013-05-27 13:47	2,543
BE Study Valganciclovir BE Study Valganciclovir BE Study Valganciclovir	drchilkoti	2013-05-24 03:27	2	2013-05-26 09:49	3,391
Change in statistical investigator from approved protocol Sit back and relax	vivekanand	2013-05-25 06:39	1	2013-05-25 10:40	2,454
change of site in a BA/BE study change of site in a BA/BE study change of site in a BA/BE study change of site in a BA/BE study change of site in a BA/BE study	jaspreet	2013-05-10 19:55	4	2013-05-24 12:14	3,916
Partial AUC Partial AUC Partial AUC Partial AUC: EMA Partial AUC	Elena	2013-05-21 22:07	4	2013-05-24 07:50	5,036
Approval from Independent EC Approval from Independent EC Approval from Independent EC	sparsh	2013-05-16 06:10	2	2013-05-23 11:29	3,326
Latest version of ASEAN BABE GL May 2012 draft May 2012 draft May 2012 draft	Helmut	2013-05-19 19:11	3	2013-05-21 12:02	4,822
accepting analytical batch Intersection and union sets Intersection and union sets FDA guidance revision	prabhakaran	2013-05-12 10:46	3	2013-05-17 13:36	3,246
Reference replicate design for Canadian submission Yes, but why? Yes, but why? Don’t use a partial replicate design!	cakhatri	2013-04-22 11:13	3	2013-05-17 12:05	5,080
Amendment in Protocol Approval by Ethics Committee Amendment in Protocol Approval by Ethics Committee	Jasim Uddin	2013-05-16 11:16	1	2013-05-16 17:27	2,546
Bibliographic application	Tina	2013-05-14 11:53	0		1,838
Q&A on the implementation of GLP in EU	ElMaestro	2013-05-10 13:43	0		1,739
Study termination Study termination Study termination Study termination	anky1212	2013-05-08 18:18	3	2013-05-09 17:59	3,163
Expired IPs	Irukulla Shravan Kumar	2013-05-09 11:12	0		1,616
QA or QP release for BA/BE/CT conducted in India	Tina	2013-05-01 14:13	0		1,766